Compare MRBK & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRBK | TOI |
|---|---|---|
| Founded | 2004 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.3M | 444.1M |
| IPO Year | 2017 | N/A |
| Metric | MRBK | TOI |
|---|---|---|
| Price | $17.23 | $3.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $18.00 | $6.00 |
| AVG Volume (30 Days) | 77.4K | ★ 2.9M |
| Earning Date | 01-23-2026 | 11-13-2025 |
| Dividend Yield | ★ 2.90% | N/A |
| EPS Growth | ★ 75.95 | N/A |
| EPS | ★ 1.77 | N/A |
| Revenue | $109,758,000.00 | ★ $461,039,000.00 |
| Revenue This Year | $26.84 | $28.51 |
| Revenue Next Year | $8.90 | $23.54 |
| P/E Ratio | $9.74 | ★ N/A |
| Revenue Growth | 18.84 | ★ 21.67 |
| 52 Week Low | $11.16 | $0.17 |
| 52 Week High | $17.43 | $4.88 |
| Indicator | MRBK | TOI |
|---|---|---|
| Relative Strength Index (RSI) | 77.07 | 59.39 |
| Support Level | $16.25 | $2.99 |
| Resistance Level | $16.59 | $3.32 |
| Average True Range (ATR) | 0.33 | 0.24 |
| MACD | 0.13 | 0.11 |
| Stochastic Oscillator | 91.70 | 86.61 |
Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.